Related Experiment Videos

Elevated circulating adhesion molecules in NIDDM--potential mediators in diabetic macroangiopathy

P Fasching, W Waldhäusl, O F Wagner

|October 1, 1996

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Long-term outcomes of a randomized, open-label, phase II study comparing cabazitaxel versus paclitaxel as neoadjuvant treatment in patients with triple-negative or luminal B/HER2-negative breast cancer (GENEVIEVE).

ESMO open·2024

Sorafenib in combination with docetaxel as first-line therapy for HER2-negative metastatic breast cancer: Final results of the randomized, double-blind, placebo-controlled phase II MADONNA study.

Breast (Edinburgh, Scotland)·2019

Clinical inertia among patients with type 2 diabetes mellitus treated with DPP-4i and/or SGLT-2i.

Diabetes research and clinical practice·2018

The HER2 phenotype of circulating tumor cells in HER2-positive early breast cancer: A translational research project of a prospective randomized phase III trial.

PloS one·2017

Willingness of Patients with Breast Cancer in the Adjuvant and Metastatic Setting to Use Electronic Surveys (ePRO) Depends on Sociodemographic Factors, Health-related Quality of Life, Disease Status and Computer Skills.

Geburtshilfe und Frauenheilkunde·2016

Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)†.

Annals of oncology : official journal of the European Society for Medical Oncology·2014

See all related articles